About US
Contact us
-
Pfizer to acquire over-the-counter Nexium marketing rights from AstraZenecaPfizer has announced it will acquire exclusive global rights to the over-the-counter (OTC) version of AstraZeneca's Nexium, a heartburn treatment, for $250m. AstraZeneca will retain the rights to man2012/8/16
-
Regulations of strenthening the supervision on pharmaceutical excipients加强药用辅料监督管理的有关规定 Regulations of strengthening the supervision management on pharmaceutical excipients 药用辅料是药品的重要组成部分，直接影响药品的质量。为进一步加强药用 辅料生产、使用的监管，确保药品质量安全，依据《中华人民共和国药品管理法》 及其实施条例、《国务院关于加强食品等产品安2012/8/14
-
NICE stiff-arms Roche melanoma drug once againRoche ($RHHBY) tried to sway the U.K.'s cost-effectiveness watchdogs toward its targeted melanoma drug Zelboraf. But it failed. The National Institute for Health and Clinical Excellence stuck to its r2012/8/14
-
It's official: Pfizer files its animal-health IPOPfizer's ($PFE) animal health unit filed its long-awaited IPO documents. As promised by CEO Ian Read at the end of last month, the newly named Zoetis unit submitted its official go-public plans to t2012/8/14
-
The Dutch Regulatory Agency has declined Cosmo Pharmaceutical's Cortiment drug for the treatment of ulcerative colitis.By Tracy Staton Sanofi wants to know its target audience of consumers with diabetes, and the French drug giant has found that social media in their multiple incarnations serve asuseful windows in2012/8/13
-
Dutch Regulatory Agency rejects Cosmo’s ulcerative colitis drugThe Dutch Regulatory Agency has declined Cosmo Pharmaceutical's Cortiment drug for the treatment of ulcerative colitis.The decision was based on "grounds of clinical relevance", but Cosmo is awaiting2012/8/13
-
The Top 10 Drug Advertising SpendsWhile the grand party in direct-to-consumer (DTC) advertising may have peaked about 5 years ago, it remains an important method of marketing drugs. The industry last year spent $2.4 billion on televis2012/8/10
-
India's Strides may put its Agila injectables unit on the blockBy Tracy Staton Shopping for an Indian drugmaker? Strides Arcolab may have a deal for you. As Bloomberg reports, Strides is apparently considering the sale of its injectables unit, Agila Specialt2012/8/10
-
Bristol-Myers Squibb executive charged with insider tradingA Bristol-Myers Squibb executive has been charged for insider trading by the Securities and Exchange Commission (SEC) in the US.The SEC alleges that Robert D Ramnarine made over $300,000 in illegal pr2012/8/9
-
Pfizer fined and Teva investigated as part of major bribery crackdownPfizer has been fined $60m by the US Securities and Exchange Commision for the bribery of foreign health officials and doctors in Eastern Europe, Asia and the Middle East, as part of a crackdown on th2012/8/9